Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900014 in Patients With Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy
Phase of Trial: Phase I
Latest Information Update: 08 Sep 2016
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 25 Aug 2016 Status changed from active, no longer recruiting to completed.
- 28 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Apr 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.